Neomer

Unlocking Therapeutic Potential: Aptamers as Promising Tools in Medicine

Aptamers, Aptamers in Diagnostics, Neomer
12 July 202331 July 2023

In recent years, the field of therapeutics has witnessed remarkable advancements in the development of novel treatment strategies. Among the emerging approaches, aptamers have emerged as powerful tools with immense potential in various therapeutic applications. Aptamers, short single-stranded nucleic acid or peptide molecules, can specifically… Read More »Unlocking Therapeutic Potential: Aptamers as Promising Tools in Medicine

Why has NeoVentures succeeded as an Aptamer development company?

Aptamers, Neomer
2 June 20232 June 2023

NeoVentures was formed as an aptamer development company in June of 2002, and founded on a very simple principle. Businesses that create real sustainable value for their clients succeed. This does not always seem to be case as we have all seen biotechnology companies that… Read More »Why has NeoVentures succeeded as an Aptamer development company?

Diagram illustrating the Neomer selection method library

Aptamer Libraries – What is Neomers?

Aptamers, Neomer
15 January 202331 January 2023

Aptamers are selected from large libraries of random sequences, thus aptamers themselves are not designed but the libraries that they are selected from are. The standard method of aptamer design has been for SELEX selection. This involves a synthetic library with a random region flanked… Read More »Aptamer Libraries – What is Neomers?

B-cells can produce antibodies that are less likely to self-bind than aptamers

How We Avoid Self-Recognition with Aptamers

Advanced, Aptamers, Introductory, Neomer
16 November 202224 November 2022

Antibody Binding vs. Aptamer Binding The immune system has developed very effective screening methods for eliminating antibodies that bind even weakly to self targets such as serum albumin and IgG. Aptamer selection is done outside the body, on the bench which provides many advantages but implicit… Read More »How We Avoid Self-Recognition with Aptamers

Scientist in a lab carefully distributing samples into multiple test tubes on a laboratory bench.

Announcing The Future of Aptamers: Neomers

Advanced, Aptamers, Introductory, Neomer
6 October 202224 November 2022

The use of the traditional SELEX method for aptamer development has led to the identification of aptamers that bind to a wide diversity of targets. However, there has been limited success with aptamers in therapeutic and diagnostic applications. A key advantage of aptamer development over… Read More »Announcing The Future of Aptamers: Neomers

How We Overcome Process Bias with Neomers

Advanced, Aptamers, Neomer
27 April 202224 November 2022

This is the first of several blogs we will share on our new Neomer process. The image above can be compared to a dilemma in traditional aptamer selection: are the aptamers that are enriching the product of the selection process (I would vote for the… Read More »How We Overcome Process Bias with Neomers